Management of the anaemia of chronic renal failure with recombinant erythropoietin.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Quarterly journal of medicine

• Publication date

  1989-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.QJMED.A068399PMID 2694210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.

  1989cited by this paper
• Recombinant human erythropoietin: implications for nephrology.

  1988cited by this paper
• Subcutaneous erythropoietin.

  1988cited by this paper
• Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in Japan

  1988cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization.

  1986cited by this paper
• Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

  1986cited by this paper
• Isolation and characterization of genomic and cDNA clones of human erythropoietin

  1985cited by this paper
• Cloning and expression of the human erythropoietin gene.

  1985cited by this paper
• Anemia of end-stage renal disease (ESRD).

  1985cited by this paper
• The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.

  1984cited by this paper
• Mechanism of the anemia of chronic renal failure.

  1980cited by this paper
• Intravenous iron dextran in clinical medicine.

  1980cited by this paper
• Effect of erythropoietin on anemia of peritoneally dialyzed anephric rats.

  1979cited by this paper
• The anemia of chronic disorders: studies of marrow regulation and iron metabolism.

  1975cited by this paper
• Hemodynamics of Uremic Anemia

  1971cited by this paper
• The kidney and erythropoiesis.

  1968cited by this paper
• Haemolysis in chronic renal failure.

  1967cited by this paper
• The bleeding disorder of uraemia. A qualitative platelet defect.

  1966cited by this paper

• Erythropoietin and Its Cardiovascular Effects

  2017cites this paper
• epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility

  2014cites this paper
• Hematopoiesis and the Kidney

  2013cites this paper
• The binding ability of alpha-1-acid glycoprotein as a mechanism of resistance to methadone

  2010cites this paper
• Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.

  2010cites this paper
• بررسی اثر ویتامین C در ترمیم گرافت پرده تمپان در عمل تمپانوپلاستی

  2009cites this paper
• [Anemia in chronic kidney disease and its cardiovascular implications].

  2009cites this paper
• PDpoetin immunogenicity compared with Eprex ,in patients undergoing mainte- nance hemodialysis

  2009cites this paper
• Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.

  2008cites this paper
• CHAPTER 95 – Hematopoiesis and the Kidney

  2008cites this paper
• Hemoglobin and Hematocrit Rise in End-Stage Renal Disease (ESRD) with PDpoetin: Results of a Phase Ш, Multicenter Clinical Trial

  2008cites this paper
• Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment

  2008cites this paper
• IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.

  2008cites this paper
• Presidential address: the illicit use of hormones for enhancement of athletic performance: a major threat to the integrity of organized athletic competition.

  2007cites this paper
• Implications of Neocytolysis for Optimal Management of Anaemia in Chronic Kidney Disease

  2007cites this paper
• Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.

  2007influential citation
• Efficacy and Safety of Oral Versus Intravenous Vitamin C in Hemodialysis Patients with Functional Iron Deficiency

  2006cites this paper
• بررسی اثر ویتامین C خوراکی و تزریقی در درمان آنمی بیماران همودیالیزی فاقد فقر آهن

  2006cites this paper
• Epoetin requirements predict mortality in hemodialysis patients.

  2004cites this paper
• The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.

  2004cites this paper
• Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.

  2003cites this paper
• Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.

  2003cites this paper
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

  2001cites this paper
• Factors and Predictors of Response with Epoetin Alfa for Chemotherapy-Related Anemia

  2000cites this paper
• Hematocrit levels and hospitalization risks in hemodialysis patients.

  1999cites this paper
• Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.

  1999cites this paper
• Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

  1999cites this paper
• Anemia na insuficiência renal crônica: novas tendências

  1999cites this paper
• Hematologic Disorders in Renal Failure

  1998cites this paper
• Resistance of anemia to rHuEPO therapy in a hemodialysis patient with cervical lymph node tuberculosis

  1997cites this paper
• Uraemic pericarditis: a reversible inflammatory state of resistance to recombinant human erythropoietin in haemodialysis patients.

  1997cites this paper
• Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

  1997cites this paper
• Hematological Problems of Renal Failure

  1996cites this paper
• The future of r-HuEPO.

  1995cites this paper
• Poor response to erythropoietin: practical guidelines on investigation and management.

  1995cites this paper
• Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure

  1995cites this paper
• The Role of Iron and Other Factors in Patients Unresponsive to Erythropoietin Therapy

  1995cites this paper
• Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme.

  1994cites this paper
• Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes.

  1994cites this paper
• Erythropoietin: the promise and the facts.

  1994cites this paper
• Quality of life and hematocrit level.

  1992cites this paper
• Phlebotomy for erythropoietin-induced malignant hypertension.

  1992cites this paper
• Erythropoietin dose requirement in a patient with HbH disease and renal failure.

  1992cites this paper
• Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans.

  1991cites this paper
• Erythropoietin deficiency in the anaemia of chronic disorders

  1991cites this paper
• Rheological studies during treatment of renal anaemia with recombinant human erythropoietin

  1991cites this paper
• Oral iron absorption in hemodialysis patients treated with erythropoietin.

  1991cites this paper
• Evidence for impaired erythropoietin response to anaemia in rheumatoid disease.

  1991cites this paper
• Phlebotomy for erythropoietin-associated malignant hypertension.

  1991cites this paper
• The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

  1991cites this paper
• Erythropoietin 1991--an overview.

  1991cites this paper
• Recombinant erythropoietin: does it really effect sensitization?

  1991cites this paper
• The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin.

  1990cites this paper
• Erythropoietin: biological aspects and clinical usefulness.

  1990cites this paper
• Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment

  1990cites this paper
• The use of recombinant human erythropoietin in humans.

  1990cites this paper
• New Insights into the Treatment of the Anemia of Chronic Renal Failure with Erythropoietin

  1990cites this paper
• Biologics: Targets and Therapy Dovepress Epoetin Zeta in the Management of Anemia Associated with Chronic Kidney Disease, Differential Pharmacology and Clinical Utility

  year unknowncites this paper